Daryl K. Granner,

Daryl K. Granner,'s AcademicInfluence.com Rankings

Daryl K. Granner,

Philosophy

#6425

World Rank

#9460

Historical Rank

Ontology

#57

World Rank

#67

Historical Rank

Logic

#3593

World Rank

#4781

Historical Rank

philosophy Degrees

Daryl K. Granner,

Biology

#8756

World Rank

#11884

Historical Rank

Endocrinology

#98

World Rank

#109

Historical Rank

Biochemistry

#1291

World Rank

#1410

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Daryl K. Granner, Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Daryl K. Granner,'s Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 (2001) (1845)
Harper's Illustrated Biochemistry (2003) (1078)
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. (1992) (844)
Epigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production* (2002) (501)
Control of specific gene expression in higher organisms. Expression of mammalian genes may be controlled by repressors acting on the translation of messenger RNA. (1969) (450)
Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence. (1984) (396)
Regulation of gene expression by insulin. (1996) (390)
Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin (1983) (307)
Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. (1984) (306)
Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. (1993) (296)
Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription. (1990) (294)
Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene (1990) (272)
The genes of hepatic glucose metabolism. (1990) (254)
Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes (1995) (227)
The orphan receptors COUP-TF and HNF-4 serve as accessory factors required for induction of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. (1995) (217)
Rat glucokinase gene: structure and regulation by insulin. (1989) (200)
Hexokinase II mRNA and gene structure, regulation by insulin, and evolution. (1993) (177)
Hormone response domains in gene transcription. (1992) (171)
Rat hepatic cytosolic phosphoenolpyruvate carboxykinase (GTP). Structures of the protein, messenger RNA, and gene. (1985) (170)
Multihormonal Regulation of Phosphoenolpyruvate Carboxykinase Gene Transcription (1986) (161)
[80] Tyrosine aminotransferase (rat liver)☆☆☆ (1970) (160)
SRC-1 and GRIP1 Coactivate Transcription with Hepatocyte Nuclear Factor 4* (1998) (146)
Regulation of gene expression by insulin. (1991) (141)
Identification of basal and cyclic AMP regulatory elements in the promoter of the phosphoenolpyruvate carboxykinase gene (1988) (136)
Molecular Physiology and Genetics of NIDDM: Importance of Metabolic Staging (1992) (134)
Phosphatidylinositol 3-Kinase, but Not p70/p85 Ribosomal S6 Protein Kinase, Is Required for the Regulation of Phosphoenolpyruvate Carboxykinase (PEPCK) Gene Expression by Insulin (1995) (134)
Insulin Regulation of Phosphoenolpyruvate Carboxykinase Gene Expression Does Not Require Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway (*) (1996) (134)
Development and regulation of glucose transporter and hexokinase expression in rat. (1994) (129)
The amino acid sequence of rat liver glucokinase deduced from cloned cDNA. (1989) (129)
Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. (1998) (126)
Stimulation of tyrosine aminotransferase synthesis by dexamethasone phosphate in cell culture. (1968) (126)
Studies on highly metabolically active acetylation and phosphorylation of histones. (1975) (125)
Lysine-rich histone phosphorylation. A positive correlation with cell replication. (1972) (122)
Tyrosine transaminase induction in mammalian cells in tissue culture. (1966) (122)
A retinoic acid response element is part of a pleiotropic domain in the phosphoenolpyruvate carboxykinase gene. (1991) (116)
The Repression of Hormone-activated PEPCK Gene Expression by Glucose Is Insulin-independent but Requires Glucose Metabolism* (1998) (116)
Analysis of the Signaling Pathway Involved in the Regulation of Hexokinase II Gene Transcription by Insulin* (1996) (116)
Multihormonal regulation of phosphoenolpyruvate carboxykinase-chloramphenicol acetyltransferase fusion genes. Insulin's effects oppose those of cAMP and dexamethasone. (1987) (114)
Tyrosine Aminotransferase: Enzyme Induction Independent of Adenosine 3',5'-Monophosphate (1968) (109)
Regulation of hexokinase II and glycogen synthase mRNA, protein, and activity in human muscle. (1995) (105)
Location and characterization of two widely separated glucocorticoid response elements in the phosphoenolpyruvate carboxykinase gene (1988) (101)
Insulin Inhibits Hepatocellular Glucose Production by Utilizing Liver-enriched Transcriptional Inhibitory Protein to Disrupt the Association of CREB-binding Protein and RNA Polymerase II with the Phosphoenolpyruvate Carboxykinase Gene Promoter* (2002) (100)
Chromatin changes accompany immunoglobulin κ gene activation: a potential control region within the gene (1982) (97)
The Effects of Hyperinsulinemia and Hyperglycemia on GLUT4 and Hexokinase II mRNA and Protein in Rat Skeletal Muscle and Adipose Tissue (1993) (97)
3' noncoding region of phosphoenolpyruvate carboxykinase mRNA contains a glucocorticoid-responsive mRNA-stabilizing element. (1989) (96)
Regulation of phosphoenolpyruvate carboxykinase gene expression by insulin. Use of the stable transfection approach to locate an insulin responsive sequence. (1990) (96)
PEPCK Gene as Model of Inhibitory Effects of Insulin on Gene Transcription (1990) (95)
Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. (1995) (94)
Synthesis and induction of tyrosine aminotransferase in synchronized hepatoma cells in culture. (1969) (94)
Rat skeletal muscle hexokinase II mRNA and activity are increased by a single bout of acute exercise. (1994) (94)
Tyrosine aminotransferase. Purificaton and characterization. (1967) (93)
The Orphan Receptor COUP-TF Binds to a Third Glucocorticoid Accessory Factor Element within the Phosphoenolpyruvate Carboxykinase Gene Promoter* (1996) (93)
CCAAT/Enhancer-binding Protein β Is an Accessory Factor for the Glucocorticoid Response from the cAMP Response Element in the Rat Phosphoenolpyruvate Carboxykinase Gene Promoter* (1999) (93)
Accessory Factors Facilitate the Binding of Glucocorticoid Receptor to the Phosphoenolpyruvate Carboxykinase Gene Promoter* (2001) (92)
Superinduction of tyrosine aminotransferase by actinomycin D in rat hepatoma (HTC) cells. (1970) (90)
Functional Organization of Mammalian Hexokinase II (1996) (88)
Prolactin-secreting pituitary tumors in amenorrheic women: a comprehensive study. (1980) (88)
New connections in the regulation of PEPCK gene expression by insulin. (1996) (88)
PATHOGENESIS OF PROLACTIN-SECRETING PITUITARY ADENOMAS (1978) (87)
Mammalian glucokinase. (1993) (87)
Dexamethasone phosphate-induced synthesis of tyrosine aminotransferase in hepatoma tissue culture cells. Studies of the early phases of induction and of the steroid requirement for maintanance of the induced rate of synthesis. (1970) (85)
Estrogen-related Receptor α Is a Repressor of Phosphoenolpyruvate Carboxykinase Gene Transcription* (2006) (84)
Activation of the phosphoenolpyruvate carboxykinase gene retinoic acid response element is dependent on a retinoic acid receptor/coregulator complex (1992) (83)
Overexpression of Hexokinase II in Transgenic Mice (1996) (83)
Hepatic nuclear factor 3 is an accessory factor required for the stimulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids. (1996) (78)
Further characterization of the glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. The role of the glucocorticoid receptor-binding sites. (1998) (77)
Potential convergence of insulin and cAMP signal transduction systems at the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter through CCAAT/enhancer binding protein (C/EBP). (1994) (76)
Insulin represses phosphoenolpyruvate carboxykinase gene transcription by causing the rapid disruption of an active transcription complex: a potential epigenetic effect. (2007) (75)
Cyclic AMP-dependent protein kinase regulates transcription of the phosphoenolpyruvate carboxykinase gene but not binding of nuclear factors to the cyclic AMP regulatory element (1990) (73)
Induction of rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase mRNA by refeeding and insulin. (1988) (72)
Structure of a nuclease-sensitive region inside the immunoglobin kappa gene: evidence for a role in gene regulation. (1983) (72)
Histone phosphorylation and DNA synthesis are linked in synchronous cultures of HTC cells. (1972) (71)
Hexokinase II overexpression improves exercise-stimulated but not insulin-stimulated muscle glucose uptake in high-fat-fed C57BL/6J mice. (2004) (68)
Regulation of hexokinase II activity and expression in human muscle by moderate exercise. (1998) (66)
Identification and Characterization of Basal and Cyclic AMP Response Elements in the Promoter of the Rat Hexokinase II Gene* (1996) (65)
Specificity of a retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter: consequences of both retinoic acid and thyroid hormone receptor binding (1991) (64)
Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats. (1993) (64)
N6,O2'-dibutyryl cycle AMP and glucose regulate the amount of messenger RNA coding for hepatic phosphoenolpyruvate carboxykinase (GTP). (1982) (63)
Acute and chronic regulation of phosphoenolpyruvate carboxykinase mRNA by insulin and glucose. (1989) (63)
The Molecular Physiology of Hepatic Nuclear Factor 3 in the Regulation of Gluconeogenesis* (2000) (63)
Identification and Characterization of a Second Retinoic Acid Response Element in the Phosphoenolpyruvate Carboxykinase Gene Promoter (*) (1996) (62)
Phosphorylation of the lysine-rich histones throughout the cell cycle. (1975) (61)
The phosphoenolpyruvate carboxykinase gene glucocorticoid response unit: identification of the functional domains of accessory factors HNF3 beta (hepatic nuclear factor-3 beta) and HNF4 and the necessity of proper alignment of their cognate binding sites. (1999) (60)
Role of Accessory Factors and Steroid Receptor Coactivator 1 in the Regulation of Phosphoenolpyruvate Carboxykinase Gene Transcription by Glucocorticoids* (2001) (59)
Signal transduction convergence: phorbol esters and insulin inhibit phosphoenolpyruvate carboxykinase gene transcription through the same 10-base-pair sequence. (1991) (59)
The effect of phorbol esters and diacylglycerol on expression of the phosphoenolpyruvate carboxykinase (GTP) gene in rat hepatoma H4IIE cells. (1986) (58)
Insulin and Glucagon Regulate Cytosolic Phosphoenolpyruvate Carboxykinase (GTP) mRNA in Rat Liver (1984) (57)
Transducin-like Enhancer of Split Proteins, the Human Homologs of Drosophila Groucho, Interact with Hepatic Nuclear Factor 3β* (2000) (57)
A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes. (2001) (57)
Biphasic effect of TSH on thyroidal iodide collection in rats. (1960) (57)
Dibutyryl cyclic AMP increases the amount of functional messenger RNA coding for tyrosine aminotransferase in rat liver. (1978) (56)
Insulin Regulates Expression of Metabolic Genes through Divergent Signaling Pathways (1999) (56)
Effects of insulin on subcellular localization of hexokinase II in human skeletal muscle in vivo. (1998) (55)
Activation of the Ras Mitogen-activated Protein Kinase-Ribosomal Protein Kinase Pathway Is Not Required for the Repression of Phosphoenolpyruvate Carboxykinase Gene Transcription by Insulin* (1998) (55)
Inhibition by sodium butyrate of enzyme induction by glucocorticoids and dibutyryl cyclic AMP. A role for the rapid form of histone acetylation. (1983) (53)
Insulin decreases phosphoenolpyruvate carboxykinase (GTP) mRNA activity by a receptor-mediated process. (1982) (53)
Transcription of the rat skeletal muscle hexokinase II gene is increased by acute exercise. (1996) (52)
Interaction of a liver-specific factor with an enhancer 4.8 kilobases upstream of the phosphoenolpyruvate carboxykinase gene (1990) (51)
Identification of a distinction between cytoplasmic histone synthesis and subsequent histone deposition within the nucleus. (1974) (50)
Human ZHX1: cloning, chromosomal location, and interaction with transcription factor NF-Y. (1999) (49)
Structural requirements of the glucocorticoid and retinoic acid response units in the phosphoenolpyruvate carboxykinase gene promoter. (1998) (48)
Human Hexokinase II mRNA and Gene Structure (1995) (48)
Protein kinase: altered regulation in a hepatoma cell line deficient in adenosine 3',5'-cyclic monophosphate-binding protein. (1972) (46)
Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter. (1995) (46)
Interaction of glucocorticoid hormones and cyclic nucleotides in induction of tyrosine aminotransferase in cultured hepatoma cells. (1977) (46)
The Synergistic Effect of Dexamethasone and All-trans-retinoic Acid on Hepatic Phosphoenolpyruvate Carboxykinase Gene Expression Involves the Coactivator p300* (2004) (45)
Identification of the insulin-regulated interaction of phosphodiesterase 3B with 14-3-3 beta protein. (2002) (45)
Glucose uptake and metabolism by cultured human skeletal muscle cells: rate-limiting steps. (2001) (45)
A Point Mutation of the AF2 Transactivation Domain of the Glucocorticoid Receptor Disrupts Its Interaction with Steroid Receptor Coactivator 1* (2002) (45)
Regulatory Actions of Glucocorticoid Hormones: From Organisms to Mechanisms. (2015) (43)
Transcription Activation by the Orphan Nuclear Receptor, Chicken Ovalbumin Upstream Promoter-Transcription Factor I (COUP-TFI) (2000) (42)
Peroxisome proliferator-activated receptor gamma coactivator-1alpha, as a transcription amplifier, is not essential for basal and hormone-induced phosphoenolpyruvate carboxykinase gene expression. (2004) (42)
Regulation of cAMP-responsive Element-binding Protein-mediated Transcription by the SNF2/SWI-related Protein, SRCAP* (2001) (41)
Turnover of deoxyribonucleic acid, histones, and lysine-rich histone phosphate in hepatoma tissue culture cells. (1972) (41)
Regulation of hexokinase II expression in human skeletal muscle in vivo. (2000) (41)
Integration of multiple signals through a complex hormone response unit in the phosphoenolpyruvate carboxykinase gene promoter. (1994) (41)
Antiglucocorticoid activity of hepatocyte nuclear factor-6. (1999) (41)
Expression of the phosphoenolpyruvate carboxykinase gene in 3T3-F442A adipose cells: opposite effects of dexamethasone and isoprenaline on transcription. (1995) (41)
Regulation of phosphoenolpyruvate carboxykinase gene transcription by insulin and cAMP: reciprocal actions on initiation and elongation. (1988) (40)
Preparation of Electro-Competent E . coli Using Salt-Free Growth Medium (39)
Oxidative and Chemical Stress Mimic Insulin by Selectively Inhibiting the Expression of Phosphoenolpyruvate Carboxykinase in Hepatoma Cells (1997) (39)
Hormonal regulation of phosphoenolpyruvate carboxykinase gene expression is mediated through modulation of an already disrupted chromatin structure (1989) (38)
Deposition of histone onto the replicating chromosome: newly synthesized histone is not found near the replication fork. (1976) (38)
Reciprocal regulation of gene transcription by insulin. Inhibition of the phosphoenolpyruvate carboxykinase gene and stimulation of gene 33 in a single cell type. (1988) (38)
Cloning and characterization of the mouse glucokinase gene locus and identification of distal liver-specific DNase I hypersensitive sites. (1995) (37)
Hexokinase II gene: structure, regulation and promoter organization. (1997) (37)
Regulation of hepatoma tissue culture cell tyrosine aminotransferase messenger ribonucleic acid by dexamethasone. (1980) (37)
Dynamic aspects of DNA/protein interactions in the transcriptional initiation complex and the hormone-responsive domains of the phosphoenolpyruvate carboxykinase promoter in vivo. (1993) (35)
Regulation of rat liver phosphoenolpyruvate carboxykinase (GTP) messenger ribonucleic acid activity by N6, O2'-dibutyryladenosine 3',5'-phosphate. (1981) (35)
Identification of Four Amino Acid Substitutions in Hexokinase II and Studies of Relationships to NIDDM, Glucose Effectiveness, and Insulin Sensitivity (1995) (34)
Relationship of Adenosine 3′,5′-Monophosphate to Growth and Metabolism of Tetrahymena pyriformis (1973) (34)
Absence of high-affinity adenosine 3',5'-monophosphate binding sites from the cytosol of three hepatic-derived cell lines. (1974) (34)
A comparison of the uptake, metabolism, and action of cyclic adenine nucleotides in cultured hepatoma cells. (1975) (33)
Induction of the messenger ribonucleic acid coding for phosphoenolpyruvate carboxykinase in H4-II-E cells. Evidence for a nuclear effect of cyclic AMP. (1982) (33)
Identification of native tyrosine aminotransferase and an explanation for the multiple forms. (1980) (33)
The inhibition of phosphoenolpyruvate carboxykinase (guanosine triphosphate) gene expression by insulin is not mediated by protein kinase C. (1987) (33)
Identification of proteins that interact with NF‐YA (1999) (33)
Expression of the phosphoenolpyruvate carboxykinase gene in 3T3-F442A adipose cells: effects of retinoic acid and differentiation. (1994) (32)
Deposition of histones onto replicating chromosomes. (1975) (32)
Elements of the Glucocorticoid and Retinoic Acid Response Units Are Involved in cAMP-mediated Expression of the PEPCK Gene* (2003) (31)
Regulation of gene expression of rat skeletal muscle/liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Isolation and characterization of a glucocorticoid response element in the first intron of the gene. (1992) (29)
Analysis of insulin-stimulated skeletal muscle glucose uptake in conscious rat using isotopic glucose analogs. (1998) (27)
Regulation of rat-liver tyrosine-aminotransferase mRNA by hydrocortisone and by N6,O2'-dibutyryladenosine 3',5'-phosphate. (1980) (27)
Relationship between chromosome condensation and metaphase lysine-rich histone phosphorylation (1976) (27)
Expression and site-directed mutagenesis of hepatic glucokinase. (1991) (26)
The effect of inhibition of deoxyribonucleic acid synthesis on histone phosphorylation. (1973) (26)
Characterization of the human liver fructose-1,6-bisphosphatase gene promoter. (2000) (26)
CHAPTER 4 – Regulation of the Synthesis of Tyrosine Aminotransferase and Phosphoenolpyruvate Carboxykinase by Glucocorticoid Hormones (1985) (26)
Evidence for a dual effect of dibutyryl cyclic AMP on the synthesis of tyrosine aminotransferase in rat liver. (1982) (26)
Rat gene 33: analysis of its structure, messenger RNA and basal promoter activity. (1989) (26)
Molecular nature of F 1 histone phosphorylation in cultured hepatoma cells. (1972) (26)
Restoration of sensitivity of cultured hepatoma cells to cyclic nucleotides shows permissive effect of dexamethasone (1976) (25)
Complex hormone response unit regulating transcription of the phosphoenolpyruvate carboxykinase gene: from metabolic pathways to molecular biology. (1991) (25)
Glucocorticoid hormones increase the activity of plasma membrane alkaline phosphodiesterase I in rat hepatoma cells. (1980) (23)
Exercise increases hexokinase II mRNA, but not activity in obesity and type 2 diabetes. (2001) (22)
Biokimia Harper Edisi.25 (2003) (22)
Translation of tyrosine aminotransferase mRNA in a modified reticulocyte system. (1977) (21)
Regulation of hexokinase II activity and expression in human muscle by moderate exercise. (1998) (21)
Physical properties, limited proteolysis, and acetylation of tyrosine aminotransferase from rat liver. (1981) (21)
Analysis of the Hexokinase II Gene in Subjects With Insulin Resistance and NIDDM and Detection of a Gln142→His Substitution (1995) (21)
REGULATION OF TYROSINE AMINOTRANSFERASE ACTIVITY IN TWO LIVER-DERIVED PERMANENT CELL LINES (1974) (20)
Insulin regulates expression of the phosphoenolpyruvate carboxykinase gene. (1986) (20)
Tweaking the glucose sensor: adjusting glucokinase activity with activator compounds. (2005) (18)
Regulation of phosphoenolpyruvate carboxykinase gene transcription in H4IIE hepatoma cells: evidence for a primary role of the catalytic subunit of 3',5'-cyclic adenosine monophosphate-dependent protein kinase. (1987) (18)
Comparison of the effects of insulin and okadaic acid on phosphoenolpyruvate carboxykinase gene expression. (1994) (18)
The phosphorylation region of lysine-rich histone in dividing cells. (1975) (17)
Efficient large-scale transformation of yeast. (1998) (17)
Suppressor T cell action inhibits the expression of an excluded immunoglobulin gene. (1983) (17)
Coexpression of glucose transporters and glucokinase in Xenopus oocytes indicates that both glucose transport and phosphorylation determine glucose utilization. (1994) (16)
Isolation and characterization of the mouse cytosolic phosphoenolpyruvate carboxykinase (GTP) gene: evidence for tissue-specific hypersensitive sites (1999) (15)
[Effect of thiocyanate, stable iodide and perchlorate on the kinetics of radioiodide transport between thyroid gland and blood of rats]. (1960) (15)
Further studies of histone phosphorylation in the presence of inhibitors of DNA synthesis. (1974) (14)
Control of glucose phosphorylation in L6 myotubes by compartmentalization, hexokinase, and glucose transport. (2003) (14)
Lack of positive correlation between adenyl cyclase activity and iodide transport in rat thyroids. (1972) (14)
The effects of HDV-insulin on carbohydrate metabolism in Type 1 diabetic patients. (2001) (14)
Insulin Decreases H4IIE Cell PEPCK mRNA by a Mechanism That Does Not Involve cAMP (1986) (14)
Poorly differentiated carcinoma of the thyroid gland. (1963) (14)
Inhibition of hepatoma cell growth by analogs of adenosine and cyclic AMP and the influence of enzymes in mammalian sera (1982) (13)
Induction of the glucokinase gene by insulin in cultured neonatal rat hepatocytes. Relationship with DNase-I hypersensitive sites and functional analysis of a putative insulin-response element. (1996) (13)
Regulation of the synthesis of tyrosine aminotransferase: the relationship to mRNATAT (2004) (13)
Examination of the phosphoenolpyruvate carboxykinase gene promoter in patients with noninsulin-dependent diabetes mellitus. (1996) (12)
Transient gene transfer into myotubes following differentiation in culture. (1996) (12)
Purification of the native form of tyrosine aminotransferase from rat liver. (1980) (12)
Cathepsin T (convertase) generates the multiple forms of tyrosine aminotransferase by limited proteolysis. (1982) (11)
Regulation by glucagon (cAMP) and insulin of the promoter of the human phosphoenolpyruvate carboxykinase gene (cytosolic) in cultured rat hepatocytes and in human hepatoblastoma cells. (2000) (11)
Transcriptional control mechanisms (1987) (11)
REGULATION OF TYROSINE AMINOTRANSFERASE mRNA IN HTC CELLS * (1980) (11)
Role of Ca(2+) fluctuations in L6 myotubes in the regulation of the hexokinase II gene. (2000) (10)
3-Aminobenzamide inhibits poly(ADP ribose) synthetase activity and induces phosphoenolpyruvate carboxykinase (GTP) in H4IIE hepatoma cells. (1988) (10)
Iodine-induced thyrotoxicosis in a woman with a multinodular goiter taking levothyroxine. (1985) (9)
Differences in thyroid function between triiodothyroninetreated and hypophysectomized rats: binding glands. (1962) (9)
The interplay of ubiquitous DNA-binding factors, availability of binding sites in the chromatin, and DNA methylation in the differential regulation of phosphoenolpyruvate carboxykinase gene expression. (1991) (9)
Biosynthetic control of the diurnal rhythm of tyrosine alpha-ketoglutarate transaminase activity in rat liver. (1970) (8)
Insulin Action Gene Regulation (2007) (8)
Tyrosine Aminotransferase PURIFICATION AND CHARACTERIZATION (2000) (7)
In Pursuit of Genes of Glucose Metabolism (2015) (7)
Kinetic analysis of thyroidal iodide concentration in hypophysectomized rats fed high or low iodine diets. (1963) (7)
Long-term culture of differentiated granulosa cells from individual bovine follicles. (1973) (7)
Compartmentalization of transport and phosphorylation of glucose in a hepatoma cell line. (2005) (7)
Diagnosis of occult familial medullary carcinoma of the thyroid using pentagastrin. (1978) (7)
Retinoid receptors cause distortion of the retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter. (1995) (7)
Multihormonal control of phosphoenolpyruvate carboxykinase gene transcription: the dominant role of insulin. (1984) (7)
Expression cloning of a zinc-finger cyclic AMP-response-element-binding protein. (1995) (7)
Insulin and phorbol esters act through the same DNA element to inhibit phosphoenolpyruvate carboxykinase gene transcription. (1992) (6)
Idiotype-specific T cell suppression of light chain mRNA expression in MOPC-315 cells is accompanied by a posttranscriptional inhibition of heavy chain expression. (1984) (6)
Improved intravenous glucose tolerance in thyroidectomized or hypophysectomized rats treated with triiodothyronine. (1959) (6)
The role of the TATA box in the hormonal regulation of phosphoenolpyruvate carboxykinase gene expression. (1995) (5)
Separation of topoisomerase I activity from the regulatory subunit of type II cyclic adenosine monophosphate-dependent protein kinase. (1988) (5)
Genetic Regulation of Glucose Metabolism (2011) (5)
Inhibition of thyroidal iodide concentrating by triiodothyronine: evidence for an effect not due to depression of thyrotrophin but dependent on the pituitary. (1959) (5)
Expression of rat hepatic glucokinase in Escherichia coli. (1989) (5)
On the steroid requirement for induction of tyrosine aminotransferase by N6, O2'-dibutyryl cyclic AMP in hepatoma cells. (1981) (5)
Variant sequences of the Hexokinase II gene in familial NIDDM (1996) (4)
Why there is an IRS. (1995) (4)
A novel (TA)n polymorphism in the hexokinase II gene: Application to noninsulin-dependent diabetes mellitus in the Pima Indians (1996) (3)
Cell specific differences in DNase I hypersensitivity between the two promoters of the rat glucokinase gene. (1995) (3)
Specificity of a retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter: consequences of both retinoic acid and thyroid hormone receptor binding (1991) (3)
Response of the thyroidal iodide pump and thyroid weight to goitrogens in rats fed low or high iodine diets. (1959) (3)
Isolation, characterization and chromosomal localization of a human pseudogene for hexokinase II. (1995) (3)
505 HKII GENE TRANSCRIPTION IS INCREASED BY ACUTE EXERCISE IN RAT SKELETAL MUSCLE (1994) (2)
Response of the thyroidal iodide pump in hypophysectomized rats on a low iodine diet to the plasma of goitrous rats. (1961) (2)
Differences in thyroid function between triiodothyroninetreated and hypophysectomized rats: blocked glands. (1962) (2)
CHAPTER 15 - Regulation of transcription by insulin (1991) (2)
The physiological importance of insulin regulated gene expression: metabolic and molecular studies. (1993) (2)
Biokimia Harper (Harpers Illustrated Biochemistry) (2009) (1)
Erratum: Hexokinase II mRNA and gene structure, regulation by insulin, and evolution (Journal of Biological Chemistry (1993) 268 (5209-5219)) (1993) (1)
A Tribute to Simon J. Pilkis 1942–1995 (1996) (1)
Oncogenic H-Ras increases glucose metabolism with an induction of glucose transporter GLUT1 and hexokinase 2 expression (2007) (1)
Evidence for a dual effect of dibutyryl cyclic AMP on the synthesis of tyrosine aminotransferase in rat liver. (1981) (1)
Explanation for the apparent inactivation of tyrosine aminotransferase in hepatoma cells by concanavalin A. (1982) (1)
POROUS NANOPARTICLES IN DRUG DELIVERY SYSTEMS (2006) (1)
Histone phosphorylation and cell division. (1971) (1)
Antiglucocorticoid activity of hepatocyte nuclear factor-6 ( liver y gene transcription y glucocorticoid receptor y 6-phosphofructo-2-kinase y phospho enol pyruvate carboxykinase ) (1999) (1)
Analysis of insulin-stimulated skeletal muscle glucose uptake in conscious rat using isotopic glucose analogs. (1998) (0)
Pepck gene transcription integration of hormonal developmental and tissue specific regulatory signals through a complex dna control domain (1992) (0)
Transcriptional control mechanisms : proceedings of a Cetus-UCLA symposium held in Keystone, Colorado, April 6-13, 1986 (1987) (0)
Figure 2, [Insulin signaling pathways potential molecular...]. (2013) (0)
HNF4 as a Liver Gene Transcription Factor (2000) (0)
skeletal muscle cells: rate-limiting steps Glucose uptake and metabolism by cultured human (2016) (0)
Recriprocal Regulation of Pepck Gene and Gene 33 Transcription by Insulin (1989) (0)
Tyrosine Aminotransferase (2000) (0)
The Inhibition of PhosphoenolpyruvateCarboxykinase(Guanosine Triphosphate) Gene Expression by Insulin is Not Mediated by Protein Kinase C* (2008) (0)
Regulation of CREB-mediated transcription by the SNF2/SWI-related protein, SRCAP (2001) (0)
Hypoxic HK2 Gene Regulation Involves Multiple Distinct Cis‐Acting Elements That Differ In Their Hypoxia‐Inducible Factor‐α (HIFα) Isoform Selectivity (2009) (0)
Hypoxic HK2 Gene Regulation Involves Multiple Distinct Cis-Acting Elements That Differ In Their Hypoxia-Inducible Factor-{alpha} (HIF{alpha}) Isoform Selectivity (2009) (0)
Hormonal regulation of assembly of the pepck gene transcription complex (2006) (0)
Stimulation of alkaline phosphodiesterase I activity by glucocorticoids in rat hepatoma cells [proceedings]. (1979) (0)
Estrogen‐Related Receptor α (ERRα) represses PGC‐1α‐activated PEPCK gene transcription (2006) (0)
QS285. GLUT 1 and Hexokinase 2 Induction by Oncogenic Ras Requires Both the Phosphoinositide 3-Kinase and Map Kinase Pathways (2008) (0)
Estrogen-Related Receptor {alpha} (ERR{alpha}) represses PGC-1{alpha}-activated PEPCK gene transcription (2006) (0)
Identification ofBasal andCyclic AMP Regulatory Elements inthe Promoter ofthePhosphoenolpyruvate Carboxykinase Gene (1988) (0)
Original articles The effects of HDV-insulin on carbohydrate metabolism in Type 1 diabetic patients (2001) (0)
Sputum cytology: a valuable addition to the investigation of hypercalcemia. (1977) (0)
Relationship ofAdenosine 3',5'-Monophosphate toGrowthandMetabolism ofTetrahymena pyriformis (1973) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Daryl K. Granner,?

Daryl K. Granner, is affiliated with the following schools:

Daryl K. Granner,'s Academic­Influence.com Rankings

Why Is Daryl K. Granner, Influential?

Daryl K. Granner,'s Published Works

Published Works

What Schools Are Affiliated With Daryl K. Granner,?

Daryl K. Granner,'s AcademicInfluence.com Rankings